Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - mometasone furoate 200ug ((anhydrous)) - powder for inhalation - 200 mcg/dose - active: mometasone furoate 200ug ((anhydrous)) excipient: lactose - asmanex twisthaler is indicated for prophylactic therapy in the management of patients with asthma of all severities, including patients who have been dependent upon either inhaled or systemically administered corticosteroids and non-corticosteroid-dependent patients inadequately controlled on other drug regimens.

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

organon (new zealand) limited - mometasone furoate 400ug ((anhydrous)) - powder for inhalation - 400 mcg/dose - active: mometasone furoate 400ug ((anhydrous)) excipient: lactose - asmanex twisthaler is indicated for prophylactic therapy in the management of patients with asthma of all severities, including patients who have been dependent upon either inhaled or systemically administered corticosteroids and non-corticosteroid-dependent patients inadequately controlled on other drug regimens.

Singapur - angličtina - HSA (Health Sciences Authority)

organon singapore pte. ltd. - mometasone furoate anhydrous - powder, metered - 100mcg/inhalation - mometasone furoate anhydrous 100mcg/inhalation

Spojené arabské emiráty - angličtina - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

city medical store - sole proprietorship l.l.c belgium - 60 metered actuations twisthaler - inhaler - 400mcg/actuatuion - respiratory system-corticosteroids

Kanada - angličtina - Health Canada

organon canada inc. - mometasone furoate - powder - 200mcg - mometasone furoate 200mcg - adrenals

Kanada - angličtina - Health Canada

organon canada inc. - mometasone furoate - powder - 100mcg - mometasone furoate 100mcg - adrenals

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - mometasone furoate - inhalation powder - 400microgram/1dose

Spojené kráľovstvo - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - mometasone furoate - inhalation powder - 200microgram/1dose

Spojené štáty - angličtina - NLM (National Library of Medicine)

merck sharp & dohme corp. - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8) - mometasone furoate 220 ug - asmanex® twisthaler® is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 4 years of age and older. limitations of use asmanex twisthaler is not indicated for the relief of acute bronchospasm. asmanex twisthaler is not indicated in children less than 4 years of age. asmanex twisthaler is contraindicated: - status asthmaticus: in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. - hypersensitivity: in patients with known hypersensitivity to milk proteins or any ingredients of asmanex twisthaler [see warnings and precautions (5.3) and description (11)]. risk summary there are no adequate and well-controlled studies of asmanex twisthaler in pregnant women. there are clinical considerations with the use of asmanex twisthaler in pregnant women [see clinical considerations] . in animal reproduction studies with pregnant mice, rats, or rabbits, mometasone furoate caused increased fetal malfo

Spojené štáty - angličtina - NLM (National Library of Medicine)

organon llc - mometasone furoate (unii: 04201gdn4r) (mometasone - unii:8hr4qj6dw8) - asmanex® twisthaler® is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients 4 years of age and older. limitations of use asmanex twisthaler is not indicated for the relief of acute bronchospasm. asmanex twisthaler is not indicated in children less than 4 years of age. asmanex twisthaler is contraindicated: - status asthmaticus: in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required. - hypersensitivity: in patients with known hypersensitivity to milk proteins or any ingredients of asmanex twisthaler [see warnings and precautions (5.3) and description (11)]. risk summary there are no adequate and well-controlled studies of asmanex twisthaler in pregnant women. there are clinical considerations with the use of asmanex twisthaler in pregnant women [see clinical considerations] . in animal reproduction studies with pregnant mice, rats, or rabbits, mometasone furoate caused increased fetal malfo